Review





Similar Products

90
ATCC ecm33 δ
C. glabrata strains used in this study
Ecm33 δ, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm33 δ/product/ATCC
Average 90 stars, based on 1 article reviews
ecm33 δ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ATCC ccug 32206
C. glabrata strains used in this study
Ccug 32206, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ccug 32206/product/ATCC
Average 90 stars, based on 1 article reviews
ccug 32206 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Schill Seilacher GmbH f. schill 32206
C. glabrata strains used in this study
F. Schill 32206, supplied by Schill Seilacher GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/f. schill 32206/product/Schill Seilacher GmbH
Average 90 stars, based on 1 article reviews
f. schill 32206 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ATCC malefermants ccug 32206t
C. glabrata strains used in this study
Malefermants Ccug 32206t, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/malefermants ccug 32206t/product/ATCC
Average 90 stars, based on 1 article reviews
malefermants ccug 32206t - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


C. glabrata strains used in this study

Journal: 3 Biotech

Article Title: Functional analysis of selected deletion mutants in Candida glabrata under hypoxia

doi: 10.1007/s13205-017-0821-7

Figure Lengend Snippet: C. glabrata strains used in this study

Article Snippet: Interestingly, no change in antifungal susceptibility of biofilm was observed for cch1 ∆, atm1 ∆ and upc2B ∆ (Table ). table ft1 table-wrap mode="anchored" t5 Table 4 caption a7 Sr. no. Strain Percent RRMA* under normoxia Percent RRMA* under hypoxia 1 pdr1 Δ 11.00 23.48 2 cch1 Δ 39.00 38.19 3 upc2B Δ 45.15 49.66 cdr1 Δ 27.64 20.18 5 ecm33 Δ 26.96 32.20 6 mid1 Δ Nil 32.92 7 kre1 Δ 04.52 31.32 8 atm1 Δ 15.58 14.02 9 rox1 Δ 11.01 34.59 10 kre2 Δ 20.36 46.14 11 ecm7 Δ 18.14 46.35 12 dun1 Δ 12.62 21.02 13 erg5 Δ 03.14 23.11 Open in a separate window * Percent RRMA relative reduction in the mean metabolic activity of biofilm in percent, with reference to the mean metabolic activity of wild-type strain, ATCC 2001 Reduction in metabolic activities of biofilm of deletion mutants when compared with the control in the presence of 16 μg ml −1 fluconazole When compared with the normoxic results, hypoxia highly increased the biofilm susceptibility to FLU for pdr1 ∆, mid1 ∆, kre1 ∆, rox1 ∆, kre2 ∆, ecm7 ∆, dun1 ∆ and erg5 ∆ deletion mutants.

Techniques:

IC 50 of fluconazole for the strains under normoxia and hypoxia

Journal: 3 Biotech

Article Title: Functional analysis of selected deletion mutants in Candida glabrata under hypoxia

doi: 10.1007/s13205-017-0821-7

Figure Lengend Snippet: IC 50 of fluconazole for the strains under normoxia and hypoxia

Article Snippet: Interestingly, no change in antifungal susceptibility of biofilm was observed for cch1 ∆, atm1 ∆ and upc2B ∆ (Table ). table ft1 table-wrap mode="anchored" t5 Table 4 caption a7 Sr. no. Strain Percent RRMA* under normoxia Percent RRMA* under hypoxia 1 pdr1 Δ 11.00 23.48 2 cch1 Δ 39.00 38.19 3 upc2B Δ 45.15 49.66 cdr1 Δ 27.64 20.18 5 ecm33 Δ 26.96 32.20 6 mid1 Δ Nil 32.92 7 kre1 Δ 04.52 31.32 8 atm1 Δ 15.58 14.02 9 rox1 Δ 11.01 34.59 10 kre2 Δ 20.36 46.14 11 ecm7 Δ 18.14 46.35 12 dun1 Δ 12.62 21.02 13 erg5 Δ 03.14 23.11 Open in a separate window * Percent RRMA relative reduction in the mean metabolic activity of biofilm in percent, with reference to the mean metabolic activity of wild-type strain, ATCC 2001 Reduction in metabolic activities of biofilm of deletion mutants when compared with the control in the presence of 16 μg ml −1 fluconazole When compared with the normoxic results, hypoxia highly increased the biofilm susceptibility to FLU for pdr1 ∆, mid1 ∆, kre1 ∆, rox1 ∆, kre2 ∆, ecm7 ∆, dun1 ∆ and erg5 ∆ deletion mutants.

Techniques:

Mean value of O.D. 492nm for biofilm of deletion mutants

Journal: 3 Biotech

Article Title: Functional analysis of selected deletion mutants in Candida glabrata under hypoxia

doi: 10.1007/s13205-017-0821-7

Figure Lengend Snippet: Mean value of O.D. 492nm for biofilm of deletion mutants

Article Snippet: Interestingly, no change in antifungal susceptibility of biofilm was observed for cch1 ∆, atm1 ∆ and upc2B ∆ (Table ). table ft1 table-wrap mode="anchored" t5 Table 4 caption a7 Sr. no. Strain Percent RRMA* under normoxia Percent RRMA* under hypoxia 1 pdr1 Δ 11.00 23.48 2 cch1 Δ 39.00 38.19 3 upc2B Δ 45.15 49.66 cdr1 Δ 27.64 20.18 5 ecm33 Δ 26.96 32.20 6 mid1 Δ Nil 32.92 7 kre1 Δ 04.52 31.32 8 atm1 Δ 15.58 14.02 9 rox1 Δ 11.01 34.59 10 kre2 Δ 20.36 46.14 11 ecm7 Δ 18.14 46.35 12 dun1 Δ 12.62 21.02 13 erg5 Δ 03.14 23.11 Open in a separate window * Percent RRMA relative reduction in the mean metabolic activity of biofilm in percent, with reference to the mean metabolic activity of wild-type strain, ATCC 2001 Reduction in metabolic activities of biofilm of deletion mutants when compared with the control in the presence of 16 μg ml −1 fluconazole When compared with the normoxic results, hypoxia highly increased the biofilm susceptibility to FLU for pdr1 ∆, mid1 ∆, kre1 ∆, rox1 ∆, kre2 ∆, ecm7 ∆, dun1 ∆ and erg5 ∆ deletion mutants.

Techniques:

Reduction in metabolic activities of biofilm of deletion mutants when compared with the control in the presence of 16 μg ml −1 fluconazole

Journal: 3 Biotech

Article Title: Functional analysis of selected deletion mutants in Candida glabrata under hypoxia

doi: 10.1007/s13205-017-0821-7

Figure Lengend Snippet: Reduction in metabolic activities of biofilm of deletion mutants when compared with the control in the presence of 16 μg ml −1 fluconazole

Article Snippet: Interestingly, no change in antifungal susceptibility of biofilm was observed for cch1 ∆, atm1 ∆ and upc2B ∆ (Table ). table ft1 table-wrap mode="anchored" t5 Table 4 caption a7 Sr. no. Strain Percent RRMA* under normoxia Percent RRMA* under hypoxia 1 pdr1 Δ 11.00 23.48 2 cch1 Δ 39.00 38.19 3 upc2B Δ 45.15 49.66 cdr1 Δ 27.64 20.18 5 ecm33 Δ 26.96 32.20 6 mid1 Δ Nil 32.92 7 kre1 Δ 04.52 31.32 8 atm1 Δ 15.58 14.02 9 rox1 Δ 11.01 34.59 10 kre2 Δ 20.36 46.14 11 ecm7 Δ 18.14 46.35 12 dun1 Δ 12.62 21.02 13 erg5 Δ 03.14 23.11 Open in a separate window * Percent RRMA relative reduction in the mean metabolic activity of biofilm in percent, with reference to the mean metabolic activity of wild-type strain, ATCC 2001 Reduction in metabolic activities of biofilm of deletion mutants when compared with the control in the presence of 16 μg ml −1 fluconazole When compared with the normoxic results, hypoxia highly increased the biofilm susceptibility to FLU for pdr1 ∆, mid1 ∆, kre1 ∆, rox1 ∆, kre2 ∆, ecm7 ∆, dun1 ∆ and erg5 ∆ deletion mutants.

Techniques: Control